Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 76087

through the advice and counsel of this Dated: November 20, 2020. Dated: November 24, 2020. group. Tyeshia M. Roberson, Miguelina Perez, Inquiries may be directed to Claire Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory Harris, Director, Office of Federal Committee Policy. Committee Policy. Advisory Committee Policy, Office of [FR Doc. 2020–26150 Filed 11–25–20; 8:45 am] [FR Doc. 2020–26369 Filed 11–25–20; 8:45 am] the Director, National Institutes of BILLING CODE 4140–01–P BILLING CODE 4140–01–P Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 20892 (Mail Stop Code 4875), Telephone (301) DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND 496–2123, or [email protected]. HUMAN SERVICES HUMAN SERVICES Dated: November 20, 2020. National Institutes of Health National Institutes of Health Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory National Institute on Aging; Notice of Government-Owned Inventions; Committee Policy. Closed Meetings Availability for Licensing [FR Doc. 2020–26167 Filed 11–25–20; 8:45 am] AGENCY: National Institutes of Health, Pursuant to section 10(d) of the BILLING CODE 4140–01–P HHS. Federal Advisory Committee Act, as amended, notice is hereby given of the ACTION: Notice. DEPARTMENT OF HEALTH AND following meetings. SUMMARY: The inventions listed below HUMAN SERVICES The meetings will be closed to the are owned by an agency of the U.S. public in accordance with the Government and are available for National Institutes of Health provisions set forth in sections licensing to achieve expeditious 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., commercialization of results of National Institute of Allergy and as amended. The grant applications and federally-funded research and Infectious Diseases; Notice of Closed the discussions could disclose development. Meeting confidential trade secrets or commercial FOR FURTHER INFORMATION CONTACT: property such as patentable material, Licensing information may be obtained Pursuant to section 10(d) of the and personal information concerning Federal Advisory Committee Act, as by communicating with Betty B. Tong, individuals associated with the grant Ph.D., National Institute of Diabetes and amended, notice is hereby given of a applications, the disclosure of which meeting of the Vaccine Research Center Digestive and Kidney Diseases, would constitute a clearly unwarranted Technology Advancement Office, 12A Board of Scientific Counselors, NIAID. invasion of personal privacy. The meeting will be closed to the public South Drive Suite 3011, Bethesda, MD as indicated below in accordance with Name of Committee: National Institute on 20892; telephone: 301–451–7836; email: the provisions set forth in sections Aging Initial Review Group; Behavior and [email protected]. A signed 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Social Science of Aging Review Committee Confidential Disclosure Agreement may NIA–S. as amended for the review, discussion, be required to receive any unpublished Date: February 4–5, 2021. information. and evaluation of individual grant Time: 11:00 a.m. to 3:00 p.m. SUPPLEMENTARY INFORMATION applications conducted by the Agenda: To review and evaluate grant : NATIONAL INSTITUTE OF ALLERGY applications. Technology description follows. AND INFECTIOUS DISEASES, Place: National Institute on Aging, Triazole Derivatives as P2Y14 Receptor including consideration of personnel Gateway Building, 7201 Wisconsin Avenue, Antagonists qualifications and performance, and the Bethesda, MD 20892 (Virtual Meeting). competence of individual investigators, Contact Person: Carmen Moten, Ph.D., The technology describes the the disclosure of which would MPH, Scientific Review Officer, Scientific composition of small molecule constitute a clearly unwarranted Review Branch, National Institute on Aging, compounds that are antagonists of the invasion of personal privacy. National Institutes of Health, Gateway Bldg., P2Y14 receptor. Also provided are 2C212, 7201 Wisconsin Avenue, Bethesda, methods of using the compounds, Name of Committee: Vaccine Research MD 20814, (301) 402–7703, cmoten@ including a method of treating a Center Board of Scientific Counselors, NIAID. mail.nih.gov. disorder, such as inflammation, Date: December 15–16, 2020. Name of Committee: National Institute on Time: 8:00 a.m. to 5:30 p.m. diabetes, insulin resistance, Aging Initial Review Group; Biological Aging hyperglycemia, a lipid disorder, obesity, Agenda: To review and evaluate grant Review Committee NIA–B. applications. a condition associated with metabolic Date: February 11–12, 2021. syndrome, and asthma, and a method of Place: National Institute of Allergy and Time: 10:00 a.m. to 6:00 p.m. Infectious Diseases, National Institutes of antagonizing P2Y14 receptor activity in Agenda: To review and evaluate grant a cell. This technology is available for Health, 40 Convent Drive, Bethesda, MD applications. 20892, (Virtual Meeting). Place: National Institute on Aging, licensing for commercial development Contact Person: John R. Mascola, MD, Gateway Building, 7201 Wisconsin Avenue, in accordance with 35 U.S.C. 209 and 37 Director, Vaccine Research Center, National Bethesda, MD 20892 (Virtual Meeting). CFR part 404. Institute of Allergy and Infectious Diseases, Contact Person: Bita Nakhai, Ph.D., Potential Commercial Applications: National Institutes of Health, 40 Convent Scientific Review Officer, Scientific Review Drive, Bethesda, MD 20892, (301) 496–1852, Branch, National Institute on Aging, National Development of P2Y14 receptor [email protected]. Institutes of Health, Gateway Bldg., 2C212, antagonist for treatment of disorders, (Catalogue of Federal Domestic Assistance 7201 Wisconsin Avenue, Bethesda, MD such as: Program Nos. 93.855, Allergy, Immunology, 20892, (301) 402–7701, [email protected]. • Inflammation and Transplantation Research; 93.856, (Catalogue of Federal Domestic Assistance • diabetes Microbiology and Infectious Diseases Program Nos. 93.866, Aging Research, • obesity Research, National Institutes of Health, HHS) National Institutes of Health, HHS) • asthma

VerDate Sep<11>2014 19:29 Nov 25, 2020 Jkt 253001 PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1 jbell on DSKJLSW7X2PROD with NOTICES